Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: A prospective study

Respiratory Medicine

Volumn 102, Issue 3, 2008, Pages 407-412

  Michalopoulos, Argyris ^a   Fotakis, Dimitrios ^a   Virtzili, Simona ^a   Vletsas, Christodoulos ^a   Raftopoulou, Sylvia ^a   Mastora, Zefi ^a   Falagas, Matthew E ^a,b  

^a HENRY DUNANT HOSPITAL   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colistin; Gram negative bacteria; ICU acquired infection; Inhaled; Polymyxins; Ventilator associated pneumonia

Indexed keywords

CEFEPIME; CEPHALOSPORIN; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULBACTAM;

ACINETOBACTER BAUMANNII; ADJUVANT THERAPY; ADULT; AEROSOL; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; APACHE; APNEA; ARTICLE; BRONCHOSPASM; CHEST TIGHTNESS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COUGHING; CRITICALLY ILL PATIENT; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUSCLE WEAKNESS; PARESTHESIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; TREATMENT DURATION; VENTILATOR ASSOCIATED PNEUMONIA; VERTIGO;

ADMINISTRATION, INHALATION; ADULT; AEROSOLS; AGED; ANTI-BACTERIAL AGENTS; COLISTIN; DRUG RESISTANCE, MULTIPLE; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 38749095520     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.10.011     Document Type: Article

References (23)

1. Kollef M. Ventilator-associated pneumonia. JAMA 270 (1993) 1965-1970
2. Garnacho-Montero J., Ortiz-Leyba C., Jimenez-Jimenez F.J., Barrero-Almodovar A.E., Garcia-Garmendia J.L., Bernabeu-Wittel M., et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis 36 (2003) 1111-1118
3. Michalopoulos A.S., Tsiodras S., Rellos K., Mentzelopoulos S., and Falagas M.E. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect 11 (2005) 115-121
4. Beringer P. The clinical use of colistin in patients with cystic fibrosis. Curr Opin Pulm Med 7 (2001) 434-440
5. Michalopoulos A., Kasiakou S.K., Mastora Z., Rellos K., Kapaskelis A.M., and Falagas M.E. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Crit Care 9 (2005) R53-R59
6. Kwa A.L., Loh C., Low J.G., Kurup A., and Tam V.H. Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Infect Dis 41 (2005) 754-757
7. Westerman E.M., Le Brun P.P.H., Touw D.J., Frijlink H.W., and Heijerman H.G.M. Effect of nebulized colistin sulphate and colistin sulphomethate on fung function in patients with cystic fibrosis: a pilot study. J Cystic Fibrosis 3 (2004) 23-28
8. Michalopoulos A., Kasiakou S., and Falagas M. The significance of different formulations of aerosolized colistin. Crit Care 9 (2005) 417-418
9. Vincent J.L., de Mendonça A., Cantraine F., et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicentric, prospective study. Crit Care Med 26 (1998) 1793-1800
10. Flanagan A.D. Adverse effects of sodium colistimethate. Ann Intern Med 74 (1971) 143-144
11. Yow E.M., Tan E., Shane L., Schonfeld S., and Abu-Nassar H. Colistin (colymycin) in resistant bacterial infections. A clinical appraisal. Arch Intern Med 108 (1961) 664-670
12. Barnett M., Bushby S.R., and Wilkinson S. Sodium sulphomethyl derivatives of polymyxins. Br J Pharmacol 23 (1964) 552-574
13. Beveridge E.G., and Martin A.J. Sodium sulphomethyl derivatives of polymyxins. Br J Pharmacol 29 (1967) 125-135
14. Falagas M., and Michalopoulos A. Polymyxins: old antibiotics come back. Lancet 367 9511 (2006) 633-634
15. Linden P.K., Kusne S., Coley K., Fontes P., Kramer D.J., and Paterson D. Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin Infect Dis 37 (2003) e154-e160
16. Valerius N.H., Koch C., and Hoiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 338 (1991) 725-726
17. Hoiby N., Frederiksen B., and Pressler T. Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibrosis Suppl. 2 (2005) 49-54
18. Conway S.P., Pond M.N., Watson A., Etherington C., Robey H.L., and Goldman M.H. Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis. Thorax 52 (1997) 987-993
19. Zylberberg H., Vargaftig J., Barbieux C., Pertuiset N., Rothschild C., and Viard J.P. Prolonged efficiency of secondary prophylaxis with colistin aerosols for respiratory infection due to Pseudomonas aeruginosa in patients infected with human immunodeficiency virus. Clin Infect Dis 23 (1996) 641-643
20. Green S.T., Nathwani D., Gourlay Y., McMenamin J., Goldberg D.J., and Kennedy D.H. Nebulized colistin (polymyxin E) for AIDS-associated Pseudomonas aeruginosa pneumonia. Int J STD AIDS 3 (1992) 130-131
21. Falagas M., Kasiakou S., Tsiodras S., and Michalopoulos A. The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature. Clin Med Res 4 (2006) 1211-1219
22. Hamer D.H. Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin. Am J Respir Crit Care Med 162 (2000) 328-330
23. Alothman G.A., Ho B., Alsaadi M.M., Ho S.L., O'Drowsky L., Louca E., et al. Bronchial constriction and inhaled colistin in cystic fibrosis. Chest 127 (2005) 522-529